<DOC>
	<DOCNO>NCT01391845</DOCNO>
	<brief_summary>Controlled ovarian stimulation ( COS ) FIV increase progesterone ( P ) estradiol ( E2 ) serum level supraphysiologic concentration end follicular phase . Elevated serum P level lead accelerate endometrial maturation interferes dialogue embryo endometrium . It report serum progesterone level ≥ 1.5 ng/ml last day COS relate significant decrease ongoing pregnancy rate follow IVF cycle . Also , report significant alteration endometrial gene expression profile relate P elevated level . Glycodelin-A immunomodulatory glycoprotein synthesize luteal-phase endometrial epithelium expression seem relate action P. Because glycodelin-A immunosuppressive activity , may facilitate process implantation maintenance pregnancy . It already know ulipristal acetate ( UPA ) decrease serum P level . The hypothesis study UPA able modify P serum level glycodelin-A endometrial expression pattern FSH/GnRH Antagonist cycle FIV .</brief_summary>
	<brief_title>Ulipristal Acetate Progesterone Levels Glycodelin-A Endometrial Pattern</brief_title>
	<detailed_description>Controlled ovarian stimulation ( COS ) FIV increase progesterone ( P ) estradiol ( E2 ) serum level supraphysiologic concentration end follicular phase . Elevated serum P level lead accelerate endometrial maturation interferes dialogue embryo endometrium . It report serum progesterone level ≥ 1.5 ng/ml last day COS relate significant decrease ongoing pregnancy rate follow IVF cycle . Also , report significant alteration endometrial gene expression profile relate P elevated level . Glycodelin-A immunomodulatory glycoprotein synthesize luteal-phase endometrial epithelium expression seem relate action P. Because glycodelin-A immunosuppressive activity , may facilitate process implantation maintenance pregnancy . Objective : evaluate endometrial effect Progesterone Glycodelin-A expression pattern woman expose ulipristal acetate GnRH Antagonist cycle use two different dos FSH ovarian control stimulation . Methods : prospective control randomize study . It enrol 16 oocyte donor Oocyte Donation Program PROAR ( Reproductive Center Rosario , Argentina ) . On day 3 menstrual cycle FSH serum level antral follicular count ( AFC ) measure . If result fulfill inclusion criterion , patient randomize FSH 225UI 300UI GnRH-Antagonist/ urinary FSH protocol . P serum level measure every 48 hour since least 1 follicle ≥14 mm achieve least 1 follicle reach 19mm diameter . The next day hCG administration new P circulating measure patient randomize trough opaque envelope receive 30mg ulipristal acetate placebo . An endometrial biopsy Cornier´s Pipelle perform 3 5 day hCG injection ( hCG+3 hCG+5 day ) evaluate endometrial date Glycodelin-A expression pattern . Statistical analysis : nominal variable analyze use t-Student test effect ulipristal ANOVA .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<criteria>Age &lt; 35 year old FSH day 3 : &lt; 12 UI/ml Antral follicular count ≥ 6 day 3 cycle BMI : &lt; 30 Kg/m2 Hypothyroidism Hyperprolactinemia Kidney liver disease Smoking Alcoholism</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>progesterone</keyword>
	<keyword>glycodelin-A</keyword>
	<keyword>ulipristal acetate</keyword>
</DOC>